




























Stem cells are characterized by their ability to divide to 
generate additional stem cells and differentiated cell 
types. Proliferative division can be symmetric or 
asymmetric, thereby one stem cell generates either two 
daughter stem cells or one stem cell plus one 
differentiated cell type, thus, triggering the expansion or 
self-renewal of the stem cell pool, respectively. Due to 
these unique features, stem cells are essential during 
embryonic development for tissue formation and during 
adulthood to ensure tissue homeostasis, repair, and 
regeneration [1-5]. 
 
The balance between cell loss and cell replacement is 
brilliantly maintained in most tissues by resident stem 
cells up to a point when such equilibrium starts to be 
progressively lost and newborn cells are not able to 
compensate for the ones that died, resulting in decline in 
tissue integrity and function and a diminished capacity 
of regeneration upon damage [2, 6]. The physiological 
loss of tissue homeostasis during life is typically 
concomitant to a progressive and extensive decline in 
the physical and cognitive performance of the whole 
organism that is commonly referred to as aging. In 
addition  to  loss  of  stem  cell  turnover,   aging  is  also  
 
 



























caused by a decrease in the overall function of 
differentiated cells that is due to a number of cell-
intrinsic and environmental factors including DNA 
damage, reduction in telomere length, oxidative stress, 
induction of stress response pathways, and production 
and accumulation of misfolded proteins, which may 
result in a number of disorders including cancer, heart 
failure, neurological diseases, and many others [7-10]. 
 
For humans, aging is one of the most evident biological 
processes whose molecular and cellular mechanisms are 
still poorly understood. Since recent studies in the field 
of stem cell biology have brought new light into the 
regenerative potential of this cell population, several 
laboratories have been prompted to investigate the use 
of stem cells for attenuating the effects of aging. It has 
been suggested that exhaustion of stem cells may be a 
primary cause of aging [11, 12] and, in fact, forcing 
regeneration leads to stem cell exhaustion and 
premature aging [13]. Certainly, stem cells can 
contribute to aging in different tissues as a reflection of 
their relative contribution to cell turnover and 
regeneration implying that organs with a low turnover 
should be minimally affected by aging of stem cells [3]. 
However, while comparing different species, the lack of 
an obvious correlation between the abundance of stem 
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allows to make any link [3]. Moreover, recent evidences 
indicate that the relative abundance of stem cells in 
certain organs does not necessarily correlate with their 
impact on organ function. Specifically, the mammalian 
brain is perhaps the organ with the lowest regenerative 
potential but the one in which the signs of aging are 
more manifested. Using the words of the renaissance 
writer Michel de Montaigne, “age imprints more 
wrinkles on the mind than it does on the face” 
indicating that age-related cognitive decline has the 
highest impact on the quality of life. To which extent 
this decline is dependent on neural stem and progenitor 
cells (together referred to as NSCs) is hard to tell but 
growing evidences indicate that, despite their negligible 
numbers, the few resident NSCs that are located in 
specific brain regions, most notably the subgranular 
zone of the hippocampus, seem to play a major role in 
cognitive functions such as learning, memory, and 
emotional behavior by generating, through intermediate 
progenitors, neurons that are constantly added to the 
brain circuitry throughout life [14-18]. 
 
Perhaps not coincidentally, aging constitutes one of the 
major factors reducing the proliferation of NSCs [19-
21] while cognitive decline, including a reduced 
learning and memory performance, is commonly 
observed in aged individuals [22-24]. Certainly, NSCs 
are not the only cause of brain aging because non-
neurogenic areas, most prominently the prefrontal 
cortex, are known to be responsible for many 
phenotypes connected to senescence including 
forgetfulness and distractibility [25-27]. A positive 
correlation between NSC activity, hippocampal 
function, and cognitive performance during aging has 
been proposed for groups of animals and single 
individuals [28-31] but other studies have challenged 
this view [32-35]. Nevertheless, manipulations that 
decrease neurogenesis typically worsen cognitive 
performance in senescent animals while, conversely, an 
increase in neurogenesis tends to improve learning and 
memory [29, 36-38]. These findings in basic stem cell 
research during aging have led to the hope that stem 
cell-based approaches might be useful to compensate, at 
least in part, the age-related cognitive decline that is 
occurring in human. In this context, it is important to 
notice that the final amount of newborn neurons 
integrating in the brain circuitry during life is controlled 
at different levels including NSCs proliferation, cell fate 
change, neuronal survival, and maturation. Given the 
importance of understanding the biology of NSCs 
during aging, in this review we discuss the present 
knowledge about the age-related changes in 
neurogenesis and its underlying mechanisms at the 
systemic, cellular, and molecular level. Particular 
attention is given to the manipulations that allowed the 
increase of neurogenesis as a potential means to 
improve cognitive performance during aging. 
 
NSCs proliferation and fate 
 
Since the original observation of Altman and Das [19], 
several studies have consistently confirmed a major 
reduction in the abundance of proliferating NSCs during 
aging from rodents to primates [20, 21, 39]. In most 
studies, BrdU labeling, eventually in combination with 
markers of cycling cells, e.g.: Ki67 or PCNA, was 
commonly used to quantify the amount of cells 
undergoing cell cycle progression. Probably as a result 
of decreased proliferation, aging was shown to correlate 
with a decrease in newly generated neurons [20, 21, 39]. 
Regarding NSCs, an important question remains as to 
whether the decrease in the number of proliferating cells 
reflects an increase in quiescence as opposed to their 
depletion. Moreover, an increase in the proportion of 
quiescent NSCs could be due to a higher number of 
cells leaving the cell cycle to become quiescent and/or a 
lower number of quiescent cells entering the cell cycle. 
Similarly, depletion of NSCs may be due to an increase 
in differentiation with concomitant loss of self-renewal 
and/or increased cell death (Figure 1). Discriminating 
between these possibilities becomes particularly 
important for studies aimed at compensating the age-
related decline in neurogenesis though manipulations of 
endogenous NSCs either by controlling their cell cycle 
entry versus exit or, alternatively, by manipulating their 
cell fate change versus survival. 
 
Certain studies based on the expression of NSCs 
markers that are independent from their proliferative 
state indicated a strong reduction in cell numbers in the 
aging hippocampus of rodents [40-42]. Conversely, 
other studies reported a change in their proliferative 
state but not in their absolute numbers [43, 44]. These 
discrepancies can partly be explained by considering 
that diverse strains, transgenic models, or even species 
were used and, in fact, it has been reported that 
senescent rodents and primates are characterized by a 
constant or decreased number of NSC, respectively 
[45]. In addition, it should be considered that the 
different markers used to characterize stem and 
progenitor cell types in different studies might identify 
slightly different cell populations. Assuming that the 
effects of aging may vary among progenitor subtypes, 
the discrepancies observed could, thus, reflect a diverse 
proportion of cell subpopulations identified using any 
specific marker within a given species. 
 
The dichotomy between depletion of NSCs versus their 
entry  in  quiescence  during  life  also  emerged  in  two  
   






















































recent works, each supporting one of two alternative 
scenarios. According to the disposable stem cell model 
[46], quiescent NSCs enter the cell cycle and undergo a 
limited number of asymmetric cell divisions after which 
they terminally differentiate into mature astrocytes, 
thus, leading to depletion of the stem cell pool during 
life. Clonal analyses by a second group reported a 
diverse behavior of NSCs with a component of 
depletion but, in addition, a significant proportion of 
quiescent as well as cycling NSCs being detected over 
long periods of time [47]. 
 
The contradicting results concerning depletion versus 
quiescence of NSCs during aging are still debated and 
even more confusion is caused by failing to appreciate 
the differences between a reversible cell cycle arrest and 
a permanent loss of proliferative potential, in which only 
the former can properly be defined to as cellular 
senescence [48]. Nevertheless, a number of studies have 
consistently shown that proliferation of NSCs in old 
animals can be induced under certain conditions, 
including physical activity [38, 49-51] and disease [44, 
52-55] indicating that, despite a partial depletion and, 
possibly, cellular senescence, a pool of NSCs is 
maintained that can be efficiently induced to re-enter the 
cell cycle and potentially contribute to improvement of 
brain function. 
 
In addition to proliferation, NSCs activity can also be 
regulated at the level of a change in their fate (e.g.: by 
changing the proportion of cells undergoing 
proliferative versus differentiative, symmetric versus 
asymmetric, and/or gliogenic versus neurogenic 
divisions). Unfortunately, “decision making” in term of 
cell fate change as a factor accounting for the reduction 
in neurogenesis during aging is also debated. In fact, a 
decrease in the number of cells acquiring a neuronal 
phenotype has been proposed [36, 38] but other studies 
reported that even if the number of proliferating NSCs 
and newborn neurons decreases during aging, the 
proportion of differentiated cell types generated from 
the pool of cycling NSCs is similar or only slightly 
changed [35, 56-58]. 
 
Nevertheless, it should be considered that developing 
approaches to compensate for the age-related decline 
in NSC activity could be achieved at any level, 
including those that are not necessarily changed 
physiologically. Thus, it becomes important not only 
to identify the physiological alterations occurring in 
the NSC niche but also to consider the systemic, 
cellular, and molecular manipulations that could be 












change  in  NSCs  fate  i.e.  an  increase  in  differentiative  at  the  expense  of
proliferative  and/or  gliogenic  at  the  expense  of  neurogenic  division  (C),
depletion  of  NSCs  by  cell  death  (D),  or  a  higher  proportion  of  newborn
neurons  undergoing  apoptosis  (E).  Continuous  or  dashed  arrows  (A‐D)
indicate  a  constant  or  decreases  proportion  of  proliferating  NSCs  and
neurons generated from the total pool of NSCs, respectively. Note that NSCs
in  E  are  not  colored  because  neuronal  death  could  potentially  occur
concomitantly to any of the previous conditions (A‐D). 
   
www.impactaging.com                     178                                          AGING,  March 2012, Vol.4 No.3Systemic effects of aging on NSCs 
 
Among the systemic changes influencing NSCs activity, 
age-related alteration in the vasculature seems to 
assume a critical role. The tight relationship and relative 
dependency between adult neurogenesis and the 
vascular niche has been consistently described [59-62]. 
However, it is not without a certain sense of frustration 
that one realizes that, similarly to NSCs quiescence, 
depletion, and fate, the effects of aging on the brain 
vasculature are also highly controversial. While no 
change in the volume of capillaries in the dentate gyrus 
has been reported [38], the opposite result has also been 
observed with a decrease in capillary volume and 
proportion of NSCs clustering in their proximity [43] 
and even without considering specifically the 
neurogenic niches conflicting reports have been 
alternatively published [63]. 
 
Perhaps more conclusively, aging was shown to 
correlate with changes in hemorheological parameters 
resulting in a diminished cerebral blood flow and a 
consequent reduced availability of oxygen, metabolites, 
and neurotrophic factors [64-66] that are important for 
NSCs and whose alterations were associated with 
impairment in spatial memory [67]. 
 
Availability of oxygen may constitute an important 
factor responsible for the reduced neurogenesis of the 
aged hippocampus. As it had emerged from a number of 
in vitro studies using embryonic-derived NSCs, 
reducing the atmospheric oxygen tension to 
physiological levels i.e. from ca. 20% to 3%, increases 
NSCs proliferation [68-71]. A similar effect is now 
being revealed in the adult brain by studies linking the 
activity of hypoxia-inducible transcription factors (HIF) 
to the induction of genes known to be involved in stem 
cell differentiation including Wnt, Notch, and BMP [72-
75]. Interestingly, aging mice display impaired hypoxic 
response including a deficiency in the activation of HIF-
1 downstream targets [76] and an initial delay in the 
angiogenic response in hypoxic conditions [77]. 
 
In addition to oxygen, systemically released factors 
have a prominent role in NSCs activity. A recent study 
showed that during heterochronic parabiosis the old 
mouse displays higher level of NSCs proliferation and 
higher number of newborn neurons due to a change in 
soluble factors, including chemokines, present in the 
plasma of the young animal [78] but no molecular link 
between these chemoattractants and NSCs proliferation 
has been established. Other blood-released factors with 
a role on adult neurogenesis and aging deserving a 
special mention include steroid hormones and growth 
factors such as corticosterone (CORT), insulin-like 
growth factor-1 (IGF-1), fibroblast growth factor-2 
(FGF-2), and vascular endothelial growth factor 
(VEGF). 
 
Glucocorticoids are steroid hormones involved in age-
related changes in the hippocampus, whose production 
and secretion by the adrenal gland are regulated by the 
hypothalamic-pituitary-adrenal axis, mainly in response 
to stress [79]. The mineralcorticoid and glucocorticoid 
receptors, strongly expressed in granule cells of the 
hippocampus [80, 81], and the latter also in NSCs [82], 
regulate gene expression upon activation by DNA 
binding of the glucocorticoid response element [79]. 
CORT is the primary glucocorticoid in rodents that 
downregulates cell proliferation in the hippocampus, as 
shown by CORT administration or adrenalectomy 
experiments in both young and senescent animals [42, 
83-86] in which a decrease in CORT levels was shown 
to correlate with improved learning and memory [29]. 
In old rodents, CORT basal level is enhanced but stress-
induced CORT increases only in the blood stream but 
not in the hippocampus [87]. In addition, expression of 
CORT receptors in NSCs and immature neurons of the 
hippocampus increases during aging [82]. 
 
Contrary to CORT, the three growth factors IGF-1, 
FGF-2 and VEGF were shown to have very similar 
effects in increasing NSCs proliferation. Expression 
and/or concentration of these factors and their receptors 
is known to decrease in the hippocampus during aging 
[88-91] and, in particular, levels of IGF-1 were shown 
to be higher, and cognitive performance to be improved, 
in long-living mutants [92]. A substantial number of 
experiments were performed to study the effects of the 
three factors on neurogenesis during adulthood or aging 
indicating a strong positive effect on NSCs proliferation 
by IGF-1 [93-95], FGF-2 [96-100], and VEGF [101-
104] signaling, with the latter also resulting in improved 
spatial memory functions [104]. To which extent these 
or other factors released in the blood can directly 
influence cognitive function during aging is currently 
debated [105, 106]. 
 
The previous findings describing the role of the 
vasculature, oxygen tension, and blood-released factors 
deserve a special emphasis in the context of the 
physiological stimulus known to have the strongest 
positive effect on NSCs proliferation: physical exercise. 
Physical exercise, like voluntary running, is a 
physiological activity known to enhance NSCs 
proliferation and neurogenesis in the adult hippocampus 
and, concomitantly, improve cognitive functions in both 
young [107, 108] and old [38, 49-51] animals. The 
increase in cell proliferation induced by running was 
shown to depend on the release of IGF-1 [109, 110] and 
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level of the vasculature [111]. 
 
Another physiological stimulus triggering systemic 
changes that correlate with a decrease in stem cell 
exhaustion and cellular senescence while, conversely, 
increasing lifespan is dietary restriction [112, 113]. 
Effects of dietary restriction are in part mediated by an 
inhibition of the mammalian target of rapamycin 
(mTOR) leading to a decreased senescence of stem and 
progenitor cells [48, 113-115] and several evidences 
indicate that these observations can be extended also to 
NSC of the adult brain [116-120]. 
 
Paradoxically, the two strongest physiological stimuli 
known to date to increase adult neurogenesis and 
lifespan, physical exercise [38, 49-51]  and dietary 
restriction [112], respectively, are the ones that current 
societies of the western world more consistently neglect 
while asking biomedical research to fill the gap. To 
achieve this, manipulation of the factors released by the 
vasculature may provide a means to better understand 
and intervene in the patho-physiology of the aging brain 
[23, 121, 122]. 
 
Cellular and molecular effects of aging on NSCs  
 
In addition to systemic effects, NSCs proliferation can 
also be influenced by cellular and molecular changes 
taking place within the neurogenic niche (Figure 2). In 
fact, not only some of the factors mentioned above but 























transcription factors known to regulate neurogenesis are 
produced locally by NSCs, astrocytes, or endothelial 
cells such as Notch, Wnt, BMP, Shh and several others 
[123-125]. Unfortunately, in the aging brain most of 
these factors were not investigated but it is interesting to 
notice that most, if not all, have been shown to inhibit 
differentiation and, in addition, shorten the cell cycle of 
NSCs [126-129]. Since the age-related reduction in 
NSCs proliferation is known to correlate with reduced 
levels of growth factors [89, 90], it would not come as a 
surprise if expression of genes regulating cell cycle 
length (or quiescence) should also be altered in the 
aging brain. In fact, expression of the inhibitors of G1 
progression p16
INK4 and p19
Arf, that were previously 
linked to cellular senescence [130], were found to 
increase in the subventricular zone of old animals [131, 
132] and deletion of p16
INK4 was shown to promote 
NSC proliferation and neurogenesis in the aged 
subventricular zone but, apparently, not in the 
hippocampus [131]. Conversely, positive regulators of 
the cell cycle, most notably cyclinD1, were found to 
decrease during aging [133]. While not considering the 
differences that could exist within progenitors subtypes 
[40], measurements of cell cycle parameters in the 
dentate gyrus of young and 10 months old (middle-
aged) rats did not detect changes in cell cycle length but 
only in the proportion of cycling cells [134] and similar 
measurements in the subventricular zone of 18 months 
old (senescent) mice corroborated this conclusion [135]. 
Interestingly, growing aged NSCs in culture was 
reported to shorten their cell cycle and induce 

























Figure  2.  Factors  influencing  neurogenesis
during aging. (From left to right) Factors and stimuli
influencing neurogenesis, their physiological increase
(yellow  arrows)  or  decrease  (blue  arrows)  during




to  correlate  with  cognitive  function.  nd=not
determined; na=not applicable. 
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factors mentioned above, also cell cycle regulators can 
control the fate of NSCs during embryonic development 
and adulthood [126-129] and even if not physiologically 
responsible for the aging phenotype, manipulation of 
cell cycle length could still be used as a strategy to 
overcome the reduction in neurogenesis occurring in 
aged animals. An impressive number of studies on cell 
cycle regulators and neurogenesis were already 
thoroughly reviewed [126-129]. Focusing exclusively 
on acute manipulations that increased neurogenesis, our 
group has recently found that expansion of NSCs can be 
achieved during embryonic development [136] and 
adulthood [137] through overexpression of the positive 
regulators of G1 progression cdk4/cyclinD1. This 
finding is consistent with the opposite effect reported in 
the adult brain after deletion of similar G1 regulators 
such as cdk6 [138] and cyclinD2 [139] and corroborate 
the notion (the cell cycle length hypothesis [140]) that 
manipulation of G1 length may influence the fate of 
somatic stem cells [128, 141]. Additional studies are 
needed to extend the cell cycle length hypothesis from 
the adult [137-139] to the senescent brain but findings 
using aged NSCs in vitro [135] makes this possibility 
likely. 
 
Neuronal maturation and survival 
 
In addition to cell proliferation and fate, neuronal 
survival strongly influences the number of neurons 
produced in the adult hippocampus. It is known that the 
vast majority of newborn neurons are eliminated by 
apoptosis in the following 6-8 weeks and that only a 
small fraction is selected for long-term survival [142]. 
However, neuronal survival does not seem to be altered 
in aged animals since birthdating experiments based on 
the comparison of BrdU positive neurons at different 
times upon labeling in old and young animals showed 
that the proportion of neurons dying after birth is 
unchanged [56-58]. Migration, dendritogenesis, and 
expression of mature markers of newborn neurons were 
delayed in old animals [56] but this effect was 
compensated at later stages [56, 143]. 
 
Even if aging does not influence neuronal death, 
physiological stimuli can still be used to increase 
survival in senescent animals. In particular, living in an 
enriched environment that provides access to social and 
inanimate stimuli, such as toys, proved to be the 
strongest physiological condition increasing the survival 
of neurons in young and aged mice [36, 144] suggesting 
that the aged brain retains a certain level of 
neuroplasticity. Similar results were obtained after long-
term exposure to enriched environment indicating an 
overall increase in the neuronal survival baseline rather 
than an acute response to new stimuli [37]. Importantly, 
increased neuronal survival in old animals positively 
correlated with a better performance in spatial memory 
tests [36, 37] end even if the molecular mechanism 
underlying this correlation is largely unknown, recent 
studies suggest a role of steroid hormone receptors [82]. 
In young mice, neuronal survival and, consequently, 
integration can be genetically enhanced, as recently 
shown after ablation of the proapoptotic gene Bax, 
leading to improvement in certain cognitive functions 
such as pattern separation [145]. As proposed by the 
authors of this work, promoting neuronal survival could 
constitute a new way to increase the number of neurons 
in old animals and, possibly, compensate age-related 




A substantial number of evidences indicate that age-
related decrease in adult neurogenesis is an important 
factor influencing cognitive performance. While several 
mechanisms may influence the number of mature 
neurons functionally integrated into the brain circuitry 
over time, the available data strongly suggests that 
aging almost exclusively acts at the level of NSC 
proliferation. Yet, the many contradicting results and 
uncertainties on identifying the exact causes of this 
“decreased proliferation” (i.e. quiescence, cellular 
senescence, cell cycle lengthening, and/or depletion via 
cell death or fate change) need to be fully acknowledged 
in order to give a rigorous and meaningful direction to 
this relatively new field. Nevertheless, in the context of 
therapy, also NSC fate, neuronal survival, and 
integration could potentially become the focus of 
interventions aimed at compensating for the decline in 
neurogenesis occurring during aging. 
 
In this perspective, significant resources are invested in 
stem cell research in the hope that basic knowledge 
could one day be used for developing treatments of age-
related cognitive decline and therapy of 
neurodegenerative diseases [146-148]. In this frame, it 
is interesting to notice that regulation of NSCs 
proliferation, although not necessarily associated with 
an increase in the number of integrated neurons, 
constitute a physiological response to certain diseases 
and that this response is maintained in aged rodents 
upon seizure [44, 52] and ischemia [53-55]. At least for 
stroke, a proliferative response has been observed in 
non-neurogenic areas also in human [149-151]. 
 
The fact that NSCs can efficiently respond to 
physiological and pathological stimuli to increase 
neurogenesis indicates that stimulation of endogenous 
NSCs offers a promising alternative to transplantation 
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but with very limited success [146-148, 152]. Proof of 
principle that increased neurogenesis in the adult 
hippocampus by acute manipulation of NSCs 
proliferation and fate [137] or neuronal survival [145] 
has been provided. Certainly, these reports fell short 
from demonstrating that a similar strategy can be 
applied in senescent mice to improve cognitive 
performance. Moreover, the studies discussed here 
indicate that a diminished neurogenesis during aging is 
primarily due to an increased quiescence and/or 
depletion of NSCs and since cdk4/cyclinD1 apparently 
changes the fate of NSCs but not their quiescence [137], 
while Bax knock-out inhibits neuronal death without 
increasing NSCs proliferation [145], it becomes 
unlikely that either of the two approaches would alone 
be sufficient to significantly improve cognitive function 
in senescent mice. 
 
The strong positive correlation between increased 
endogenous neurogenesis and improved cognitive 
performance in senescent mice has already been 
provided upon life-long manipulation of blood-released 
factors [29] or acute exposure to physiological stimuli 
[38, 49-51]. It remains to be shown whether these 
effects can be reproduced by more specific 
manipulations triggering the appropriate combination of 
changes at the level of NSCs quiescence, fate, neuronal 
survival, and/or integration to improve cognitive 
performance in senescent individuals; even despite a 
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